Initiatives developed by the IS team seek to strategically advance the field to promote the next generation of implementation studies to more rapidly improve population and public health.
The initial Consortium for Cancer Implementation Science (CCIS) meeting, held July 2019, delved into three main categories of focus: building capacity, increasing collaboration, and supporting implementation science activities in cancer. CCIS seeks to develop a new approach for the field to work together to address key challenges and identify and develop new areas of investigation towards advancing the implementation science agenda in cancer control. Learn more about CCIS.
These collaborative research centers, supported through the Cancer MoonshotSM, are designed to improve cancer control through creation of “laboratories” that study implementation efforts in clinical and community settings, develop novel IS methods and measures, execute innovative pilot projects, enhance data resources, and disseminate results among the cancer research community. The goal of the network is to reduce the burden of cancer by enhancing the design and delivery of implementation strategies for evidence-based cancer control. Learn more about ISC3.
The EBCCP website is a searchable database of cancer control programs and implementation materials. EBCCP gives program planners and public health practitioners easy and immediate access to evidence-based materials. The site outlines programs available for use in a community or clinical setting. Currently, there are over 200 programs available on the EBCCP website across many health topics (e.g., tobacco control, HPV vaccination, cancer screening, survivorship/supportive care), delivery settings (e.g., community- and faith-based organizations, schools, clinical settings), and target populations (e.g., adolescents, adults, blacks, Hispanics or Latinos, Asians, whites).
Sponsored by NCI, the Speeding Research-tested Interventions (SPRINT) program was designed to foster, grow, and nurture an innovation ecosystem for interventionists. The program curriculum was developed and delivered by instructors with extensive startup and teaching experience, providing hands-on training and engagement with industry to successfully transform cancer control innovations into market-ready products. The goal was to create research-tested behavioral interventions that are ready to be put into real-world practice.